Nanopatterned 3D Vascularized Functional Muscle Patch
Nanopatterned 3D Vascularized Functional Muscle Patch
批准号:
8636918
负责人:
Deok-Ho Kim
金额:
$19.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2016-03-31
关键词:
AdultAffectArchitectureBiochemicalBiocompatible MaterialsBlood VesselsBungarotoxinsCell Culture TechniquesCell SurvivalCell TherapyCell fusionCellsCessation of lifeChemistryComplexConfocal MicroscopyDevelopmentDiseaseDuchenne muscular dystrophyDystrophinEndothelial CellsEngineeringEngraftmentExtracellular MatrixFiberFibrinFibrin Tissue AdhesiveGeometryGoalsImmunocompromised HostImmunohistochemistryImplantIntramuscularIsolectinLengthLimb structureLongevityMeasuresModalityMolecularMusMuscleMuscle CellsMuscle ContractionMuscle FibersMuscle TensionMuscle functionMuscular DystrophiesMyographyMyopathyNanotopographyNatural regenerationNeuromuscular JunctionPatientsPatternPlayPolymersProcessPropertyRoleSkeletal MuscleStaining methodStainsStem cellsStructureSupporting CellSystemTechniquesTestingTissue EngineeringTissuesTransgenic MiceTransplantationUnited StatesVascularizationWeight-Bearing stateWestern BlottingWorkloadangiogenesisbasecell motilitycontrolled releasecytochemistrydisabilityfunctional restorationimplantationinorganic phosphateintravital imagingmalemdx mousemouse modelmuscle formmuscle regenerationmuscular dystrophy mouse modelmuscular structuremyogenesisnanoengineeringnanometernanopatternnanostructuredneurofilamentpublic health relevancereconstructionrelease of sequestered calcium ion into cytoplasmrepairedsatellite cellscaffoldsphingosine 1-phosphatestem cell therapysuccesstherapy development
中文摘要
描述(由申请人提供):杜氏肌营养不良症(DMD)是一种致命疾病,在美国每3500名男性中就有一人患有此病,导致严重残疾和死亡。尽管卫星细胞有内源性再生骨骼肌的能力,但由于细胞存活率低、保留率低和植入不理想,肌内移植的成功程度非常有限。骨骼肌由以高度各向异性排列的高度条纹细胞组成,附着在由许多纳米范围内特征尺寸的纤维组成的细胞外基质(ECM)上,以高保真度延伸到各种长度尺度。我们之前的研究表明,为细胞提供基于ECM的支持,模拟天然肌肉ECM纳米形貌,可以为干细胞排列和融合形成成熟肌肉提供生理相关的微环境。我们还发现并证明了spigosine - 1-phosphate (S1P)作为一种有效的血管生成和肌生成因子的作用。本提案的总体目标是开发纳米模式,各向异性3D肌肉组织贴片,密切模仿天然骨骼肌结构,然后在DMD小鼠模型中测试其整合和恢复肌肉功能的能力。我们将把基于纳米形貌的组织工程方法与细胞薄片操作技术和S1P疗法结合起来,生成血管化肌肉组织的无支架3D贴片。表达Pax7Cre/flox GCaMP3的原代肌肉内皮细胞和卫星细胞将被培养在纳米形貌确定的、具有可调几何形状的热响应底物上,以促进肌肉发生并产生各向异性细胞片。这些薄片将堆叠形成3D肌肉结构,在移植前将进行分子、结构和功能分析。我们将测试我们的3D组织结构与营养不良肌肉整合的能力,提供干细胞库,恢复营养不良蛋白的表达,并加强肌肉萎缩小鼠的肢体肌肉。具体目标包括:(1)利用纳米图案细胞薄片操作技术开发血管化的3D肌肉贴片;(2)在杜氏肌营养不良小鼠模型中植入1-磷酸鞘氨醇偶联纤维蛋白三维肌肉贴片,并评估其恢复肌肉功能的效果。
英文摘要
DESCRIPTION (provided by applicant): Duchenne muscular dystrophy (DMD) is a lethal disease that affects one in every 3500 males in the United States, causing severe disabilities and death. Despite the capacity of satellite cells to endogenously regenerate skeletal muscle, intramuscular transplantation efforts have shown very limited success due to poor cell survival, low retention, and suboptimal engraftment. Skeletal muscle consists of highly striated cells arranged in a highly anisotropic manner, attached to an extracellular matrix (ECM) composed of many fibers of feature sizes in the nanometer range, extending for various length scales with high fidelity. Our previous studies suggest that providing an ECM-based support for cells, mimicking the native muscle ECM nanotopography, can provide a physiologically relevant microenvironment for the stem cells to align and fuse together to form mature muscle. We also identified and demonstrated the role of sphigosine 1-phosphate (S1P) as a potent angiogenic and myogenic factor. The overall goals of this proposal are to develop nanopatterned, anisotropic 3D muscle tissue patches that closely mimic native skeletal muscle structure and then to test their ability to integrate and restore muscle function in a mouse model of DMD. We will combine a nanotopography-based tissue engineering approach with cell sheet manipulation techniques and S1P therapy to generate scaffold free 3D patches of vascularized muscle tissues. Primary muscle endothelial and satellite cells expressing Pax7Cre/flox GCaMP3 will be cultured on nanotopographically-defined, thermoresponsive substrates with tunable geometries to promote myogenesis and create anisotropic cell sheets. These sheets will be stacked to form 3D muscle constructs that will undergo molecular, structural, and functional analyses prior to transplantation. We will test our 3D tissue construct's ability to integrate with dystrophic muscle provide a stem cell reservoir, restore dystrophin expression and strengthen limb muscles in muscular dystrophy mice. Specific aims include: (1) to develop vascularized 3D muscle patches using nanopatterned cell sheet manipulation techniques; and (2) to implant and evaluate 3D muscle patches with sphingosine 1-phosphate conjugated fibrin to restore muscle function in a mouse model of Duchenne muscular dystrophy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High-throughput nanoIEA-based Assay for Screening Immune Cell-Vascular Interactions
-
批准号:10592897
-
项目类别:
-
资助金额:$21.17万
-
财政年份:2023
-
负责人:Deok-Ho Kim
-
依托单位:
Microphysiological Model of Human Cardiac Sympathetic Innervation
-
批准号:10502626
-
项目类别:
-
资助金额:$74.18万
-
财政年份:2022
-
负责人:Deok-Ho Kim
-
依托单位:
Microphysiological Model of Human Cardiac Sympathetic Innervation
-
批准号:10869757
-
项目类别:
-
资助金额:$7.42万
-
财政年份:2022
-
负责人:Deok-Ho Kim
-
依托单位:
Microphysiological Model of Human Cardiac Sympathetic Innervation
-
批准号:10861445
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2022
-
负责人:Deok-Ho Kim
-
依托单位:
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity
-
批准号:10632929
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2022
-
负责人:Deok-Ho Kim
-
依托单位:
Microphysiological Model of Human Cardiac Sympathetic Innervation
-
批准号:10636892
-
项目类别:
-
资助金额:$71.56万
-
财政年份:2022
-
负责人:Deok-Ho Kim
-
依托单位:
Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes
-
批准号:10179233
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2021
-
负责人:Deok-Ho Kim
-
依托单位:
Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes
-
批准号:10378025
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2021
-
负责人:Deok-Ho Kim
-
依托单位:
Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes
-
批准号:10661492
-
项目类别:
-
资助金额:$56.98万
-
财政年份:2021
-
负责人:Deok-Ho Kim
-
依托单位:
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY
-
批准号:10164856
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2020
-
负责人:Deok-Ho Kim
-
依托单位:
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY
-
批准号:10116566
-
项目类别:
-
资助金额:$52.09万
-
财政年份:2020
-
负责人:Deok-Ho Kim
-
依托单位:
DISEASE MODELING AND PHENOTYPIC DRUG SCREENING FOR DYSTROPHIC CARDIOMYOPATHY
-
批准号:10396049
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2020
-
负责人:Deok-Ho Kim
-
依托单位:
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity
-
批准号:10434471
-
项目类别:
-
资助金额:$8.04万
-
财政年份:2018
-
负责人:Deok-Ho Kim
-
依托单位:
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity
-
批准号:10268228
-
项目类别:
-
资助金额:$75.77万
-
财政年份:2018
-
负责人:Deok-Ho Kim
-
依托单位:
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity
-
批准号:9791191
-
项目类别:
-
资助金额:$42.15万
-
财政年份:2018
-
负责人:Deok-Ho Kim
-
依托单位:
A Human iPSC-based 3D Microphysiological System for Modeling Cardiac Dysfunction in Microgravity
-
批准号:10460801
-
项目类别:
-
资助金额:$5.79万
-
财政年份:2018
-
负责人:Deok-Ho Kim
-
依托单位:
A HUMAN IPSC-BASED 3D MICROPHYSIOLOGICAL SYSTEM FOR MODELING CARDIAC DYSFUNCTION IN MICROGRAVITY
-
批准号:10175489
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2018
-
负责人:Deok-Ho Kim
-
依托单位:
Tissue Engineered Human Neuromuscular Junctions for Modeling Axonal Neuropathy
-
批准号:9235682
-
项目类别:
-
资助金额:$34.73万
-
财政年份:2016
-
负责人:Deok-Ho Kim
-
依托单位:
TISSUE ENGINEERED HUMAN NEUROMUSCULAR JUNCTIONS FOR MODELING AXONAL NEUROPATHY
-
批准号:10054199
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2016
-
负责人:Deok-Ho Kim
-
依托单位:
Injectable myocardial matrix-grapheme composite hydrogels for functional cardiac tissue engineering
-
批准号:9034827
-
项目类别:
-
资助金额:$22.75万
-
财政年份:2016
-
负责人:Deok-Ho Kim
-
依托单位:
海外基金